Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.

Liu, Miao; Liu, Siyao; Yang, Liu; Wang, Shu

Liu, Miao; Liu, Siyao; Yang, Liu; Wang, Shu.

Affiliation

Liu M; Breast Center, Peking University People's Hospital, Beijing, China.
Liu S; Breast Center, Peking University People's Hospital, Beijing, China.
Yang L; Breast Center, Peking University People's Hospital, Beijing, China.
Wang S; Breast Center, Peking University People's Hospital, Beijing, China. shuwang@pkuph.edu.cn.

BMC Cancer ; 21(1): 118, 2021 Feb 04.

Article in En | MEDLINE | ID: mdl-33541289

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Solvents/chemistry; Albumins/administration & dosage; Breast Neoplasms/pathology; Female; Humans; Paclitaxel/administration & dosage; Prognosis; Randomized Controlled Trials as Topic; Taxoids/administration & dosage

Key words

Albumin-bound paclitaxel; Breast cancer; Meta-analysis; Neoadjuvant chemotherapy; Paclitaxel

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Solvents / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google